Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor

Hybridoma

Volumn 25, Issue 3, 2006, Pages 115-124

  Wei, Ping ^a   Zhan, Jinghui ^a   Liu, Shuying ^a   Chang, David ^a   Haldankar, Raj ^a   Burkhardt, Kim ^a   Crouse, Jill ^a   Hui, John ^a   Juan, Todd ^a   Talvenheimo, Jane ^a   Kim, Helen ^a   Li, Luke ^a   Boone, Tom ^a   Borges, Luis ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2C; KERATINOCYTE GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HYBRIDOMA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; TECHNOLOGY; TISSUE DISTRIBUTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;

MURINAE;

EID: 33745656364     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.25.115     Document Type: Article

References (20)

1. Johnson DE and Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993;60:1-41.
2. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, and Aaronson SA: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 1992;89:246-250.
3. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, and Lonai P: Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993;158:475-486.
4. Finch PW, Cunha GR, Rubin JS, Wong J, and Ron D: Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 1995;203:223-240.
5. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, and Dickson C: An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000;127:483-492.
6. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, and Itoh N: FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000;277:643-649.
7. Petiot A, Conti FJ, Grose R, Revest JM, Hodivala-Dilke KM, and Dickson C: A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development 2003;130: 5493-5501.
8. Finch PW and Rubin JS: Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 2004;91:69-136.
9. Guo L, Degenstein L, and Fuchs E: Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996;10:165-175.
10. Chen Y, Chou K, Fuchs E, Havran WL, and Boismenu R: Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 2002;99:14338-14343.
11. Spielberger R, Stiff P, Bensinger W, et al: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-2598.
12. Ishiwata T, Naito Z, Lu YP, Kawahara K, Fujii T, Kawamoto Y, Teduka K, and Sugisaki Y: Differential distribution of fibroblast growth factor (FGF)-7 and FGF-10 in L-arginine-induced acute pancreatitis. Exp Mol Pathol 2002;73:181-190.
13. Yamamoto-Fukuda, T, Aoki D, Hishikawa Y, Kobayashi T, Takahashi H, and Koji T: Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma. Lab Invest 2003;83:123-136.
14. Kilpatrick KE, Wring SA, Walker DH, et al: Rapid development of affinity matured monoclonal antibodies using RIMMS. Hybridoma 1997;16:381-389.
15. Hsu YR, Nybo R, Sullivan JK, et al: Heparin is essential for a single keratinocyte growth factor molecule to bind and form a complex with two molecules of the extracellular domain of its receptor. Biochemistry 1999;38:2523-2534.
16. Plotnikov AN, Hubbard SR, Schleissinger J, and Mohammadi M: Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000;101:413-424.
17. Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, and Mohammadi M: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc Natl Acad Sci USA 2003;100:2266-2271.
18. Leijon K, Hammarstrom B, and Holmberg D: Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 1994;6:339-345.
19. Ridgway WM, Fasso M, and Fathman CG: A new look at MHC and autoimmune disease. Science 1999;284:749-751.
20. Kishimoto H and Sprent J: A defect in central tolerance in NOD mice. Nat Immunol 2001;2:1025-1031.